EU Pharmaceutical Legislation: ISPOR Plenary Day 2

By João L. Carapinha

November 14, 2023

Introduction The European Union stands at the threshold of significant change with its proposed EU ...
The Power of Telehealth and CGM Technology in Diabetes Management
Medical Device Procurement: Unravelling the Role of Health Technology Assessment
ISPOR CEO Rob Abbott Advocates for HEOR in Global Healthcare Decision Making
The Power of Innovation Centres in US Healthcare
Improving Healthcare Delivery: The FDA and CMS Policy Alignment for Cardiovas...
Increased Cardiovascular Implantable Electronic Device Infections
Pioneering Pain Management: High-Frequency Electrical Stimulation Devices
A New Framework for Assessing Digital Health Technologies
The Future of Health Technology Assessment (HTA) in Greece: Trends and Predic...
Unleashing the Potential of Gene Therapies: Overcoming HTA Challenges
Sacubitril-Valsartan: A Cost-Effective Solution for Heart Failure Management
Direct-Acting Oral Anticoagulants: A Comparative Study on Value and Pricing